GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO

Watchlist Manager
GlaxoSmithKline Pharmaceuticals Ltd Logo
GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
Watchlist
Price: 2 457.1499 INR 0.18%
Market Cap: 416.3B INR
Have any thoughts about
GlaxoSmithKline Pharmaceuticals Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

43.1
Current
34.4
Median
17.2
Industry
Higher than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
43.1
=
Enterprise Value
398.6B INR
/
EBIT
9.3B INR
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
36.7
2-Years Forward
EV/EBIT
32.1
3-Years Forward
EV/EBIT
N/A

See Also

Discover More